◀ Back to AR

AR — VAV3

Pathways - manually collected, often from reviews:

• NCI Pathway Database Coregulation of Androgen receptor activity: VAV3 (VAV3) → AR/T-DHT complex (AR) (transcription, activates) Lyons et al., Mol Endocrinol 2006*
  Evidence: mutant phenotype, reporter gene

Text-mined interactions from Literome

Dong et al., Mol Endocrinol 2006 (Prostatic Neoplasms) : Overexpression of Vav3 enhanced androgen receptor (AR) activity regardless of the presence or absence of androgen and stimulated the promoters of AR target genes
Peacock et al., Mol Endocrinol 2012 (Neoplasms, Hormone-Dependent...) : Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival
Nomura et al., Molecular cancer 2013 (MAP Kinase Signaling System...) : Vav3 enhances androgen receptor (AR) activity during progression to androgen independence in prostate cancer